KetoSwiss is a privately held Swiss biotechnology company located in Basel, that develops a novel nutraceutical / medical food (“MigraKet”) for the dietary preventive therapy of higher-frequency migraines and possibly other related diseases characterized by a metabolic dysfunction (such as Alzheimer's Disease). The lead product’s active substance is an endogenous metabolite – a ketone body, which can be used by the brain as an alternative fuel to glucose, when glucose utilization or transport is compromised. Due to our modern carbohydrate-rich diets our brains rely almost exclusively on glucose. This can contribute to an energy-deficiency in the brain and in turn neurological diseases, such as migraine or Alzheimers, which are known to have a metabolic component to it. During fasting / glucose restriction our livers produce an alternative, more effective fuel source for the brain called ketone bodies. KetoSwiss strives to bring human identical ketone bodies back into our modern world. We develop potent, clinically tested, Swiss quality ketone body products (esp. medical foods) to combat neurological civilisation diseases.
In brief, KetoSwiss makes fuel for brains.
KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where the company is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem. KetoSwiss enjoys broad access to state-of-the art infrastructure as well as laboratories to grow its operations.